Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Hebang Biotechnology Co Days Payable Chart
For the Chemicals subindustry, Sichuan Hebang Biotechnology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sichuan Hebang Biotechnology Co Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Sichuan Hebang Biotechnology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Sichuan Hebang Biotechnology Co's Days Payable falls into.
Sichuan Hebang Biotechnology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sichuan Hebang Biotechnology Co (SHSE:603077) has a Days Payable of 75.28 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sichuan Hebang Biotechnology Co and its competitors. This is near median its historical median of 80.15. Over the past decade, Sichuan Hebang Biotechnology Co's Days Payable has ranged from 56.15 to 101.20. According to the industry distribution chart, Sichuan Hebang Biotechnology Co ranks #658 out of 1553 companies in the Chemicals industry, placing it in the top 42.4%.
Is Sichuan Hebang Biotechnology Co's Days Payable too high?
Sichuan Hebang Biotechnology Co's current Days Payable of 75.28 is near median its 10-year median of 80.15. Over the past 10 years, this metric has ranged from a low of 56.15 to a high of 101.20. The Chemicals industry median Days Payable is 59.87. Sichuan Hebang Biotechnology Co's value of 75.28 is 25.7% above this industry median. Based on the distribution chart, Sichuan Hebang Biotechnology Co ranks #658 out of 1553 companies in the Chemicals industry, which is above the industry midpoint. Overall, Sichuan Hebang Biotechnology Co has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Sichuan Hebang Biotechnology Co's Days Payable compare to DOW?
According to the Chemicals industry distribution chart, Sichuan Hebang Biotechnology Co ranks #658 out of 1553 companies for Days Payable. This puts Sichuan Hebang Biotechnology Co in the upper half of its industry. The industry median Days Payable is 59.87. Sichuan Hebang Biotechnology Co's value of 75.28 is 25.7% above this benchmark. Historically, Sichuan Hebang Biotechnology Co's own Days Payable has ranged from 56.15 to 101.20 over the past decade. While the company's 10-year median is 80.15 vs. the industry median of 59.87, Sichuan Hebang Biotechnology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.87, based on 1,553 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sichuan Hebang Biotechnology Co's current Days Payable of 75.28 is 25.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sichuan Hebang Biotechnology Co and its competitors. For the Chemicals industry, the median Days Payable is 59.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sichuan Hebang Biotechnology Co's current Days Payable is 75.28, which is near median its own 10-year median of 80.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sichuan Hebang Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Sichuan Hebang Biotechnology Co (SHSE:603077) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥1.32, compared to a current price of ¥2.37 — trading 79.5% above its estimated fair value. The current Days Payable is 75.28, which is near median its 10-year median of 80.15 and 25.7% above the Chemicals industry median of 59.87. Sichuan Hebang Biotechnology Co's overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sichuan Hebang Biotechnology Co (SHSE:603077), the current Days Payable is 75.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sichuan Hebang Biotechnology Co (SHSE:603077) Overvalued in 2026?
Based on GuruFocus' analysis, Sichuan Hebang Biotechnology Co stock appears to be overvalued.
The current stock price of ¥2.37 is trading 79.5% above its estimated GF Value™ of ¥1.32.
GuruFocus considers Sichuan Hebang Biotechnology Co to be Significantly Overvalued.
Key valuation signals for SHSE:603077:
Days Payable: 75.28 (near median its 10-year median of 80.15)
GF Value™: ¥1.32 vs. price of ¥2.37 (79.5% above fair value)
Industry Position: 25.7% above the Chemicals median (#658 of 1553)
No single metric tells the full story. See the SHSE:603077 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603077 has been successfully added to your 
